Komori
Other Disclosures7776CellSeed Inc.Electrical Equipment and Precision Instruments

Notice Regarding the Decision to Grant a Patent for a Japanese Patent Application Relating to a Cartilage Regeneration Sheet

The Company's Japanese patent application relating to a cartilage regeneration sheet has received a decision to grant a patent. Progress has been made toward securing rights to the results of the allogeneic chondrocyte sheet joint research conducted with Tokai University.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

Cartilage regeneration sheet; allogeneic chondrocyte sheet
Applicable field (uses covered by this announcement)

Evaluation of cartilage-like tissue formation properties; production and evaluation of cell cultures

Relationship between the counterparty and the company
CellSeed Inc.7776
Relationship with the Company

Conducted joint research on allogeneic chondrocyte sheets

CounterpartyTokai University
Registration number and expiry date

Japanese Patent Application No. 2022-506860; filing date: 12 March 2021; decision to grant a patent

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredCartilage regeneration sheet; allogeneic chondrocyte sheet
CounterpartyTokai University
Relationship with the CompanyConducted joint research on allogeneic chondrocyte sheets
Applicable areaEvaluation of cartilage-like tissue formation properties; production and evaluation of cell cultures
Registration number and expiry dateJapanese Patent Application No. 2022-506860; filing date: 12 March 2021; decision to grant a patent
Items this document does not state (13)
Counterparty overviewContract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because this is the result of the joint research on allogeneic chondrocyte sheets conducted with Tokai University.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Decision to Grant a Patent for a Japanese Patent Application Relating to a Cartilage Regeneration Sheet | CellSeed Inc. (7776) timely disclosure | Komori